Evidence map›Paper›PMID 35491735›Full record

ArticleAddiction (Abingdon, England)2022

Response to McIlveen et al.: Collaboration and transparency are necessary to effectively estimate substance use disorder treatment need.

Elizabeth D Nesoff, Megan E Marziali, Silvia S Martins

Abstract readLetterComment
In one paragraph

Article in Addiction (Abingdon, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Elizabeth D NesoffDepartment of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.ORCID 0000-0001-8562-8646
Megan E MarzialiDepartment of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.ORCID 0000-0002-8845-663X
Silvia S MartinsDepartment of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.ORCID 0000-0003-3059-9993

Funding

Substance Abuse Epidemiology Training Program (SAETP) at Columbia UniversityT32DA031099 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DEBORAH S HASIN, Silvia Saboia Martins · 2012 to 2026
$6.1M
State medical marijuana laws and NSDUH marijuana use and consequences since 2004R01DA037866 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MARTINS, SILVIA SABOIA · 2014 to 2018
$2.3M
Adulterants, drugs, coingestants and associated HIV riskR01DA018572 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BOYER, EDWARD W · 2005 to 2008
$1.4M
Neighborhoods, Mental Health, and the Prevention of Opioid Overdose: A Mixed Methods ApproachK01DA049900 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI NESOFF, ELIZABETH · 2020 to 2024
$851k
NIDA NIH HHS K01 DA049900NIDA NIH HHS R01 DA018572NIDA NIH HHS R01 DA037866NIDA NIH HHS T32 DA031099
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BuprenorphineOpioid-Related DisordersHumansBuprenorphineCOVID-19medication for opioid use disorderspolicysubstance use disordertreatmentunmet treatment need

Identifiers

PMID35491735
PMCPMC9872911

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.